Skip to content
Home / Companies / AVTX AVT
Avalo Therapeutics, Inc. (AVTX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest AVTX Insider Trades
About Avalo Therapeutics, Inc. (AVTX) Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Headquarters WAYNE, PA
Employees 33
Listed 2015
Exchange XNAS https://www.avalotx.com SEC filings for AVTX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 9 84,163 $1.68M Grant or award 10 172,454 Option exercise 18 161,270
AVTX Insider Transactions (Form 4) 73 62 Form 4 filings on record, the earliest from Nov 14, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value May 6, 2026 CS Christopher Ryan Sullivan - Officer Option exercise Common Stock 47,000
Recent AVTX Form 8-K Filings 5
Recent AVTX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 18, 2026 CHRISTOPHER RYAN SULLIVAN Officer 31,031 $622K View on EDGAR Aug 17, 2026 CHRISTOPHER RYAN SULLIVAN Officer
AVTX Insider Trading - FAQ
What is the latest insider trade for AVTX? Avalo Therapeutics, Inc. (AVTX) had 21 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for AVTX runs to 62 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AVTX stock? No insider purchases of AVTX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling AVTX stock? 9 insider sales of AVTX were filed in the last 90 days, totaling $1.68M.
Where can I see AVTX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks AVTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AVTX insider buys? Create a free InsiderAlpha account and press Watch on this page to add AVTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track AVTX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $1.05B
P/E ratio -
Dividend yield -
Average volume 1.30M
52 week high $24.27
52 week low $8.65
Today's high $20.18
Today's low $19.54
Open $19.87
Volume 738.3K
Previous close $20.05
Shares outstanding 53.63M Market cap
$1.05B
33 employees
AVTX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 9 sales totaling $1.68M.
Most-Active AVTX Insiders - Last 90 Days 10 Tax withholding / forfeiture 4 2,891
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
May 5, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 1,000 $12.65 $13K
May 5, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 679 $8.04 $5K
May 5, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 1,679 $16.00 $27K
May 6, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 77,905 $12.65 $985K
May 6, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 28,650 $8.04 $230K
May 6, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 77,905 $0.00 -
May 6, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 28,650 $0.00 -
May 6, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 27,538 $18.03 $496K
May 6, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 5,000 $19.65 $98K
May 6, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 44,944 $21.20 $953K
May 6, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 19,015 $22.41 $426K
May 6, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 10,058 $22.88 $230K
May 5, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 1,000 $0.00 -
May 5, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 679 $0.00 -
May 6, 2026 MC Mitchell Chan Open-market sale Common Stock 3,167 $22.88 $72K
Apr 6, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 3,970 $12.65 $50K
Apr 6, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 3,970 $18.01 $72K
Apr 6, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 3,970 $0.00 -
Apr 1, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 679 $8.04 $5K
Apr 1, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 679 $16.00 $11K
Apr 1, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 679 $0.00 -
Mar 31, 2026 RJ Rita Jain Grant or award Stock Option (Right to Buy) 1,339 $12.13 $16K
Mar 31, 2026 KL Kevin Robert Lind Grant or award Stock Option (Right to Buy) 1,370 $12.13 $17K
Mar 28, 2026 ST Samantha Truex Option exercise Restricted Stock Units 3,166 $0.00 -
Mar 28, 2026 AK Aaron Kantoff Option exercise Restricted Stock Units 3,166 $0.00 -
Mar 28, 2026 GK Gilla Kaplan Option exercise Common Stock 3,166 - -
Mar 28, 2026 GK Gilla Kaplan Option exercise Restricted Stock Units 3,166 $0.00 -
Mar 28, 2026 GN Garry Arthur Neil - Officer Tax withholding / forfeiture Common Stock 21,892 $13.89 $304K
Mar 28, 2026 GN Garry Arthur Neil - Officer Option exercise Restricted Stock Units 64,866 $0.00 -
Mar 28, 2026 MC Mitchell Chan Option exercise Restricted Stock Units 3,166 $0.00 -
Mar 16, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 19,500 $12.65 $247K
Mar 16, 2026 MD Mittie Doyle - Officer Option exercise Common Stock 5,992 $8.04 $48K
Mar 16, 2026 MD Mittie Doyle - Officer Open-market sale Common Stock 25,492 $16.15 $412K
Mar 16, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 19,500 $0.00 -
Mar 16, 2026 MD Mittie Doyle - Officer Option exercise Stock Option (Right to Buy) 5,992 $0.00 -
Feb 26, 2026 PV Paul Varki - Officer Grant or award Stock Option (Right to Buy) 80,000 $0.00 -
Feb 26, 2026 JR Jennifer Riley - Officer Grant or award Stock Option (Right to Buy) 95,000 $0.00 -
Feb 26, 2026 MD Mittie Doyle - Officer Grant or award Stock Option (Right to Buy) 105,000 $0.00 -
Feb 26, 2026 TB Taylor Boyd - Officer Grant or award Stock Option (Right to Buy) 95,000 $0.00 -
Feb 26, 2026 GN Garry Arthur Neil - Officer Grant or award Stock Option (Right to Buy) 286,000 $0.00 -
Dec 31, 2025 KL Kevin Robert Lind - Director Grant or award Stock Option (Right to Buy) 848 $14.74 $12K
Dec 31, 2025 RJ Rita Jain - Director Grant or award Stock Option (Right to Buy) 1,043 $14.74 $15K
Nov 14, 2025 JG Jonathan Goldman - Director Open-market sale Common Stock 3,167 $14.30 $45K
Nov 14, 2025 JG Jonathan Goldman - Director Option exercise Common Stock 8,200 $9.88 $81K
Nov 14, 2025 JG Jonathan Goldman - Director Open-market sale Common Stock 8,200 $14.35 $118K
Nov 14, 2025 JG Jonathan Goldman - Director Option exercise Stock Option (Right to Buy) 8,200 $0.00 -
Oct 1, 2025 KL Kevin Robert Lind - Director Grant or award Stock Option (Right to Buy) 40,200 $0.00 -
Oct 1, 2025 TB Taylor Boyd - Officer Grant or award Stock Option (Right to Buy) 275,000 $0.00 -
Sep 30, 2025 RJ Rita Jain - Director Grant or award Stock Option (Right to Buy) 1,572 $0.00 -
Jun 17, 2025 GK Gilla Kaplan - Director Grant or award Stock Option (Right to Buy) 20,100 $0.00 -
$IONS
IONIS PHARMACEUTICALS INC
